RANDOMISED TRIAL OF INTRAVENOUS RECOMBINANT TISSUE-TYPE PLASMINOGEN ACTIVATOR VERSUS INTRAVENOUS STREPTOKINASE IN ACUTE MYOCARDIAL INFARCTION

This publication has 25 references indexed in Scilit:

• Coronary thrombolysis with recombinant human tissue-type plasminogen activator: a prospective, randomized, placebo-controlled trial.
  Circulation, 1984
• Coronary Thrombolysis for Evolving Myocardial Infarction
  Drugs, 1984
• Coronary thrombolysis with recombinant human tissue-type plasminogen activator.
  Circulation, 1984
• Thrombolytic Therapy
  New England Journal of Medicine, 1984
• Improvement of regional myocardial metabolism after coronary thrombolysis induced with tissue-type plasminogen activator or streptokinase.
  Circulation, 1984
• Coronary Thrombolysis with Tissue-Type Plasminogen Activator in Patients with Evolving Myocardial Infarction
  New England Journal of Medicine, 1984
• Coronary thrombolysis with intravenously administered human tissue-type plasminogen activator produced by recombinant DNA technology.
  Circulation, 1984
• Cardiovascular reflexes stimulated by reperfusion of ischemic myocardium in acute myocardial infarction.
  Circulation, 1983
• Reperfusion arrhythmia: A marker of restoration of antegrade flow during intracoronary thrombolysis for acute myocardial infarction
  American Heart Journal, 1983
• A Table of Exact Confidence Limits for Differences and Ratios of Two Proportions and Their Odds Ratios
  Journal of the American Statistical Association, 1977